Josefine Bostner

Josefine Bostner

UNVERIFIED PROFILE

Are you Josefine Bostner?   Register this Author

Register author
Josefine Bostner

Josefine Bostner

Publications by authors named "Josefine Bostner"

Are you Josefine Bostner?   Register this Author

9Publications

279Reads

21Profile Views

Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.

Breast Cancer Res Treat 2018 Feb 11;168(1):17-27. Epub 2017 Nov 11.

Department of Clinical and Experimental Medicine, and Department of Oncology, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4508-x
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4508-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847064PMC
February 2018

ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer.

Clin Cancer Res 2016 Mar 5;22(6):1421-31. Epub 2015 Nov 5.

Department of Biology; Stern College for Women of Yeshiva University; New York, New York. Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, New York. Albert Einstein Cancer Center; Albert Einstein College of Medicine; Bronx, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0857DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794381PMC
March 2016

S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts.

Endocr Relat Cancer 2015 Jun;22(3):331-43

Department of Clinical and Experimental MedicineDepartment of OncologyDepartment of Clinical and Experimental MedicineDivision of Dermatology, Linköping University, SE-58185 Linköping, SwedenDepartment of OncologyKarolinska University Hospital, Karolinska Institute, SE-17176 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-14-0513DOI Listing
June 2015

Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit.

Breast Cancer Res Treat 2013 Jan 15;137(2):397-406. Epub 2012 Dec 15.

Division of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University & County Council of Östergötland, SE-581 85, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2376-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539073PMC
January 2013

High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.

Genes Chromosomes Cancer 2011 Oct 11;50(10):775-87. Epub 2011 Jul 11.

Department of Clinical and Experimental Medicine, Division of Oncology, Faculty of Health Sciences, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20900DOI Listing
October 2011

Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer.

Clin Cancer Res 2010 Mar 23;16(5):1624-33. Epub 2010 Feb 23.

Division of Surgery and Clinical Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-1733DOI Listing
March 2010